Annual ROE
-19.62%
+3.08%+13.57%
December 31, 2023
Summary
- As of February 7, 2025, ABOS annual return on equity is -19.62%, with the most recent change of +3.08% (+13.57%) on December 31, 2023.
- During the last 3 years, ABOS annual ROE has fallen by -59.02% (-149.80%).
- ABOS annual ROE is now -128.34% below its all-time high of 69.24%, reached on December 31, 2019.
Performance
ABOS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-32.99%
-8.36%-33.94%
September 30, 2024
Summary
- As of February 7, 2025, ABOS quarterly return on equity is -32.99%, with the most recent change of -8.36% (-33.94%) on September 30, 2024.
- Over the past year, ABOS quarterly ROE has dropped by -9.13% (-38.26%).
- ABOS quarterly ROE is now -120.42% below its all-time high of 161.52%, reached on June 30, 2021.
Performance
ABOS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ABOS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.6% | -38.3% |
| 3 y3 years | -149.8% | -30.1% |
| 5 y5 years | -128.3% | -30.1% |
ABOS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +56.1% | -130.5% | +74.8% |
| 5 y | 5-year | -128.3% | +56.1% | -120.4% | +94.4% |
| alltime | all time | -128.3% | +56.1% | -120.4% | +94.4% |
Acumen Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -32.99%(+33.9%) |
| Jun 2024 | - | -24.63%(+7.7%) |
| Mar 2024 | - | -22.87%(-2.3%) |
| Dec 2023 | -19.62%(-13.6%) | -23.40%(-1.9%) |
| Sep 2023 | - | -23.86%(-5.9%) |
| Jun 2023 | - | -25.36%(+8.6%) |
| Mar 2023 | - | -23.36%(+10.1%) |
| Dec 2022 | -22.70% | -21.21%(+16.8%) |
| Sep 2022 | - | -18.16%(+26.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | -14.31%(-75.4%) |
| Mar 2022 | - | -58.21%(-55.6%) |
| Dec 2021 | -44.68%(-213.4%) | -131.08%(-77.7%) |
| Sep 2021 | - | -588.42%(-464.3%) |
| Jun 2021 | - | 161.52%(+60.3%) |
| Mar 2021 | - | 100.78%(+155.8%) |
| Dec 2020 | 39.40%(-43.1%) | - |
| Dec 2020 | - | 39.40% |
| Dec 2019 | 69.24% | - |
FAQ
- What is Acumen Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals annual ROE year-on-year change?
- What is Acumen Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals quarterly ROE year-on-year change?
What is Acumen Pharmaceuticals annual return on equity?
The current annual ROE of ABOS is -19.62%
What is the all time high annual ROE for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high annual return on equity is 69.24%
What is Acumen Pharmaceuticals annual ROE year-on-year change?
Over the past year, ABOS annual return on equity has changed by +3.08% (+13.57%)
What is Acumen Pharmaceuticals quarterly return on equity?
The current quarterly ROE of ABOS is -32.99%
What is the all time high quarterly ROE for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high quarterly return on equity is 161.52%
What is Acumen Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, ABOS quarterly return on equity has changed by -9.13% (-38.26%)